Clinical Trial Update: Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating levofloxacin-based concomitant therapy for eradicating Helicobacter pylori in diabetic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Chung-Tai Wu | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED